Used in pharmaceutical research as a key intermediate for synthesizing bioactive compounds, particularly those targeting central nervous system disorders. Shows potential in the development of nicotinic acetylcholine receptor modulators, which are investigated for cognitive enhancement and treatment of neurodegenerative diseases like Alzheimer's. Also explored in the design of antidepressants and anti-addiction therapies due to its structural affinity to nicotinic ligands. Employed in medicinal chemistry for structure-activity relationship studies to optimize drug candidates with improved selectivity and pharmacokinetic profiles.